Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2016-08-09 Interim / Quarterly Rep…
Country US United States of America
Listing US NVAX

About NOVAVAX INC

https://www.novavax.com/?locale=US

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report Q2 2016
2016-08-09 English
FORM 4 SUBMISSION
Director's Dealing
2016-08-02 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 9, 2016, for Novavax, Inc. It reports the submission of matters to a vote of security holders at the annual meeting held on that date. The content includes detailed voting results on director elections, stock incentive plans, employee stock purchase plans, and auditor ratification. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4037 characters, which is short but contains substantive voting results, not just an announcement of a report. Therefore, it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). The document is not an Annual Report, Earnings Release, or any other category. Hence, the correct classification is DVA with high confidence.
2016-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2016-06-07 English
FORM 4 SUBMISSION
Director's Dealing
2016-05-25 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 4, 2016, reporting the company's financial results for the quarter ended March 31, 2016. It references a press release attached as Exhibit 99.1 containing the financial results. The document itself is a current report announcing the earnings results, not the full quarterly report. The length is 3399 characters, which is relatively short and consistent with an earnings release announcement rather than a full interim report. Therefore, this document is best classified as an Earnings Release (ER).
2016-05-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.